MIRASOL
Device
Terumo BCT, Inc.
Total Payments
$247,386
Transactions
13
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $247,386 | 13 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $247,386 | 13 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MIPLATE | Terumo BCT, Inc. | $170,298 | 0 |
| Mechanisms of Experimental Acute Lung Injury | Terumo BCT, Inc. | $41,935 | 0 |
| Effects of UV Exposure during Mirasol Treatment on White Blood Cells | Terumo BCT, Inc. | $18,196 | 0 |
| Effects of UV Exposure during Mirasol Treatment on Red Blood Cells | Terumo BCT, Inc. | $16,957 | 0 |
Top Doctors Receiving Payments for MIRASOL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $247,386 | 13 |
Ad
Manufacturing Companies
- Terumo BCT, Inc. $247,386
Product Information
- Type Device
- Total Payments $247,386
- Total Doctors 0
- Transactions 13
About MIRASOL
MIRASOL is a device associated with $247,386 in payments to 0 healthcare providers, recorded across 13 transactions in the CMS Open Payments database. The primary manufacturer is Terumo BCT, Inc..
Payment data is available from 2017 to 2017. In 2017, $247,386 was paid across 13 transactions to 0 doctors.
The most common payment nature for MIRASOL is "Unspecified" ($247,386, 100.0% of total).
MIRASOL is associated with 4 research studies, including "MIPLATE" ($170,298).